Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Acq. announced Director departure CC transcript Quarterly results
|
Aegerion Pharmaceuticals, Inc. (AEGR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/24/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
10/20/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
09/12/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
08/10/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
08/09/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/21/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/17/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/16/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/16/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/16/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/15/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/15/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/15/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/15/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
|
|